INTERMEDIATE RISK PROSTATE CANCER
Clinical trials for INTERMEDIATE RISK PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new INTERMEDIATE RISK PROSTATE CANCER trials appear
Sign up with your email to follow new studies for INTERMEDIATE RISK PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New NanoKnife treatment shows promise for prostate cancer
Disease control CompletedThis study tested a device called NanoKnife to treat prostate cancer in 121 men with intermediate-risk disease. The goal was to safely destroy cancer tissue while avoiding major side effects. Researchers checked if the treated area was cancer-free after 12 months and tracked any …
Matched conditions: INTERMEDIATE RISK PROSTATE CANCER
Phase: NA • Sponsor: Angiodynamics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Prostate cancer radiation showdown: which treatment wins?
Disease control CompletedThis study compared two types of radiation therapy for men with intermediate-risk prostate cancer: standard image-guided external beam radiation (IGRT) versus IGRT plus a high-dose-rate brachytherapy boost. The goal was to see which treatment works better and what side effects oc…
Matched conditions: INTERMEDIATE RISK PROSTATE CANCER
Phase: NA • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Microwave zaps prostate tumors with 3D precision
Disease control CompletedThis study tested a new way to treat intermediate-risk prostate cancer using a 3D map to guide microwaves directly to the main tumor. 76 men across Europe received the treatment, and researchers checked if the cancer was gone after 12 months. The goal is to destroy the cancer whi…
Matched conditions: INTERMEDIATE RISK PROSTATE CANCER
Phase: NA • Sponsor: Koelis • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Hormone therapy boost for prostate cancer radiation shows promise
Disease control CompletedThis large phase 3 trial studied 1,538 men with intermediate-risk prostate cancer. It compared dose-escalated radiation therapy alone versus radiation plus short-term (6 months) androgen deprivation therapy (hormone therapy). The goal was to see if adding hormone therapy improves…
Matched conditions: INTERMEDIATE RISK PROSTATE CANCER
Phase: PHASE3 • Sponsor: Radiation Therapy Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Prostate cancer radiation showdown: does adding external beam help?
Disease control CompletedThis study looked at 588 men with intermediate-risk prostate cancer to see if adding external beam radiation to brachytherapy (placing radioactive seeds in the prostate) works better than brachytherapy alone. The goal was to see which approach better controls the cancer over time…
Matched conditions: INTERMEDIATE RISK PROSTATE CANCER
Phase: PHASE3 • Sponsor: Radiation Therapy Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC